Zymeworks Inc.

ZYME · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $2.0B · 264 employees
100
SEC Filings
$25.61
Close 2026-05-22
264
Employees

Business Summary

PART I Overview Zymeworks is a global biotechnology company managing a portfolio of licensed healthcare assets and developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat conditions, including cancer, inflammation, and autoimmune disease. We believe our asset and royalty aggregation strategy differentiates us from other biotechnology companies because it provides us with an opportunity to optimize future milestone and royalty...

Latest Stock Quote

ZYME 2026-05-22 $25.61 O:$25.2 H:$25.68 L:$24.94 Vol:0.5M VWAP:$25.4891
origin leaf: 3a2eb8cf1f2da223a995819c0bad8a6a4925d6067ccffa91927644b0c0f085ae

Next Earnings

Q2 FY2026 — expected 2026-09-06

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-022025-12-310001937653-26-000015EDGAR115K words
2025-03-052024-12-310001937653-25-000014EDGAR
2024-03-062023-12-310001937653-24-000019EDGAR
2023-03-072022-12-310001937653-23-000011EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001937653-25-000077EDGAR65K words
2025-08-072025-06-300001937653-25-000049EDGAR
2025-05-082025-03-310001937653-25-000027EDGAR
2024-10-312024-09-300001937653-24-000050EDGAR
2024-08-012024-06-300001937653-24-000041EDGAR
2024-05-022024-03-310001937653-24-000028EDGAR
2023-11-072023-09-300001937653-23-000037EDGAR
2023-08-102023-06-300001937653-23-000028EDGAR
2023-05-082023-03-310001937653-23-000018EDGAR
2022-11-082022-09-300001937653-22-000009EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-010001193125-26-135610EDGAR12K words
2026-03-020001193125-26-084082EDGAR
2026-03-020001937653-26-000013EDGAR
2026-01-120001193125-26-010480EDGAR
2025-12-300001193125-25-337268EDGAR
2025-11-180001193125-25-285259EDGAR
2025-11-170001193125-25-283873EDGAR
2025-11-060001937653-25-000076EDGAR
2025-09-020001193125-25-193351EDGAR
2025-08-110001193125-25-177505EDGAR

100 total filings indexed. 76 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001937653
TickerZYME
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.zymeworks.com
Listed2017-04-28

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 4e4f7e74a401e3c8bff6ded95d1b51811d9fc15dfe0f31fba44319fd307d7ae8
parent: c9c8b1ccbeca85689f181bb2e30269fc35dce389f5588eeafb5ae2eb10a37fed
content hash: a72f05afdd8f0291922122426b93d8927da614620d13f1def602b6003d9ab36e
signed: 2026-06-02T19:03:15.059Z
sources: 15 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf